Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 0.48 |
| ▸ | TERT | O14746 | 1/20 | 0.48 |
| ▸ | APAF1 | O14727 | 1/20 | 0.45 |
| ▸ | KDM1A | O60341 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 4/20 | 0.39 |
| ▸ | NCK1 | P16333 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Blue Cation SCHEMBL12312491 | 0.91 | APP (0.57) | APPTERTAPAF1KDM1AALDH1A1 | |
| Methylene Blue Cation SCHEMBL12312497 | 0.91 | APP (0.57) | APPTERTAPAF1KDM1AALDH1A1 | |
| Methylene Blue Cation SCHEMBL128584 | 0.91 | APP (0.57) | APPTERTAPAF1KDM1AALDH1A1 | |
| Methylene Blue Cation SCHEMBL29941578 | 0.91 | APP (0.57) | APPTERTAPAF1KDM1AALDH1A1 | |
| Methylene Blue Cation SCHEMBL12312498 | 0.91 | APP (0.57) | APPTERTAPAF1KDM1AALDH1A1 | |
| Methylene Blue Cation SCHEMBL109755 | 0.91 | APP (0.57) | APPTERTAPAF1KDM1AALDH1A1 | |
| Methylene Blue Cation SCHEMBL1461350 | 0.89 | APP (0.55) | APPTERTAPAF1ALDH1A1TSHR | |
| Methylene Blue Cation SCHEMBL1207285 | 0.89 | APP (0.55) | APPTERTAPAF1KDM1AALDH1A1 | |
| Methylene Blue Cation SCHEMBL1926028 | 0.89 | APP (0.55) | APPTERTAPAF1KDM1AALDH1A1 | |
| Methylene Blue Cation SCHEMBL4565666 | 0.89 | APP (0.55) | APPTERTAPAF1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170267652-A1 | PROCESS FOR THE PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | EUPHARMA PTY LTD (AU) | 2017-09-21 | — | — | US | disclosed |
| US-9701648-B2 | Process for the purification of diaminophenothiazinium compounds | EUPHARMA PTY LTD (AU) | 2017-07-11 | — | — | US | disclosed |
| US-20170002393-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | IMMUNOGEN, INC. (US) | 2017-01-05 | — | — | US | disclosed |
| US-20160200696-A1 | PROCESS FOR THE PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | EUPHARMA PTY LTD (AU) | 2016-07-14 | — | — | US | disclosed |
| US-8921243-B2 | Fabrics comprising a photocatalyst to produce singlet oxygen from ambient oxygen | VENTANA RESEARCH CORPORATION | 2014-12-30 | — | — | US | disclosed |
| US-8679990-B2 | Self-decontaminating coatings and fabrics | LOMBARDI JOHN L (US) | 2014-03-25 | — | — | US | disclosed |
| US-20120135651-A1 | Fabrics Comprising a Photocatalyst to Produce Singlet Oxygen from Ambient Oxygen | VENTANA RESEARCH CORPORATION | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267652-A1 | PROCESS FOR THE PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | QDPR, DDC, DDT | APP 1000/4885TERT 1874/4885APAF1 3666/4885 |
| US-20160200696-A1 | PROCESS FOR THE PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | QDPR, MAOB, DDC | APP 823/4885TERT 1778/4885APAF1 4543/4885 |
| US-20170002393-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | TXNRD1, P4HB, CYBB | APP 2393/4885TERT 4054/4885APAF1 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.